LIP
LLY icon

Liontrust Investment Partners’s Eli Lilly LLY Stock Holding History

Liontrust Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.5M Buy
38,794
+8,041
+26% +$8.22M 0.68% 50
2026
Q1 		$28.3M Buy
30,753
+9,788
+47% +$9.92M 0.48% 57
2025
Q4 		$22.5M Sell
20,965
-32,891
-61% -$31.4M 0.33% 66
2025
Q3 		$41.1M Sell
53,856
-1,204
-2% -$896K 0.6% 48
2025
Q2 		$42.9M Buy
55,060
+23,501
+74% +$18.3M 0.61% 46
2025
Q1 		$26.1M Sell
31,559
-7,686
-20% -$6.4M 0.41% 55
2024
Q4 		$30.3M Buy
39,245
+13,745
+54% +$11.4M 0.44% 50
2024
Q3 		$23.1M Hold
25,500
– – 0.33% 59
2024
Q2 		$23.1M Buy
25,500
+3,000
+13% +$2.4M 0.33% 59
2024
Q1 		$17.5M Sell
22,500
-10,500
-32% -$7.47M 0.24% 74
2023
Q4 		$19.2M Buy
33,000
+17,500
+113% +$10.2M 0.28% 62
2023
Q3 		$8.33M Buy
+15,500
New +$7.99M 0.13% 98

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Liontrust Investment Partners's LLY Position: Q2 2026 in Review

Liontrust Investment Partners increased its Eli Lilly (LLY) stake by 26% in Q2 2026, buying an estimated $8.22M and bringing the position to 38,794 shares worth $46.5M. The position accounts for 0.68% of the portfolio, ranked #50.

Liontrust Investment Partners first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Liontrust Investment Partners held 38,794 shares of Eli Lilly worth $46.5M as of Q2 2026.
  • Liontrust Investment Partners bought 8,041 Eli Lilly shares in Q2 2026, an estimated $8.22M.
  • Eli Lilly made up 0.68% of Liontrust Investment Partners's portfolio in Q2 2026, its #50 holding.
  • Liontrust Investment Partners first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Liontrust Investment Partners's 13F filing for Q2 2026, filed 18 Aug 2026.